<DOC>
	<DOCNO>NCT00557440</DOCNO>
	<brief_summary>This study design provide data 24 hour FEV1 profile , safety tolerability indacaterol/mometasone TWISTHALER device compare placebo use fluticasone/salmeterol active control .</brief_summary>
	<brief_title>Investigation 24 Hour Forced Expiratory Flow 1 Second ( FEV1 ) Profile Single Dose Indacaterol/Mometasone Delivered Via TWISTHALER® Device Adult Patients With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Male female adult patient age 1875 year ( inclusive ) , sign Informed Consent Form prior initiation studyrelated procedure , Patients persistent asthma , diagnose accord Global Initiative Asthma ( GINA ) guideline ( National Institute Health , National Heart , Lung Blood Institute , 2006 ) additionally meet follow criterion : Patients receive daily treatment inhale corticosteroid maximum dose per day indicate product label , stable regimen month prior Visit 1 . Patients FEV1 Visit 1 ≥50 % predict normal . Patients demonstrate increase ≥ 12 % ≥ 200 mL FEV1 prebronchodilator . Pregnant woman , nurse mother , female childbearing potential , regardless whether sexually active , use reliable form contraception . Patients use tobacco product within 6 month period prior Visit 1 , smoke history great 10 pack year . Patients diagnose Chronic Obstructive Pulmonary disease ( COPD ) define GOLD guideline ( Global Initiative Chronic Obstructive Lung Disease 2006 ) . Patients seasonal allergy whose asthma likely deteriorate study period . Patients acute asthma attack/exacerbation require hospitalization 6 month prior Visit 1 . Patients acute asthma attack / exacerbation require emergency room visit within 6 week prior Visit 1 time Visit 1 Visit 2 . Patients respiratory tract infection within 4 week prior Visit 1 time Visit 1 Visit 2 . Patients history long QT interval syndrome whose QT interval correct heart rate ( QTc ) interval ( Bazett 's ) measure Visit 1 Visit 2 prolong : &gt; 450 m ( male ) &gt; 470 m ( female ) . Other clinically significant condition may interfere study conduct patient safety specify protocol . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>QMF</keyword>
	<keyword>Indacaterol</keyword>
	<keyword>Mometasone</keyword>
</DOC>